These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38012977)

  • 1. Next generation device interrogation for the HeartMate 3.
    Grinstein J; Ziegler LA; Shah P
    J Heart Lung Transplant; 2024 Feb; 43(2):261-262. PubMed ID: 38012977
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of bend relief disconnection in patients supported by a HeartMate II left ventricular assist device.
    Waller AH; Dunne R; Stewart GC; Ghosh N; Gosev I; Rybicki FJ; Blankstein R; Couper GS; Steigner M
    Circ Cardiovasc Imaging; 2014 Sep; 7(5):844-8. PubMed ID: 25227237
    [No Abstract]   [Full Text] [Related]  

  • 3. HeartMate 3: Facing the challenge of past success.
    Stansfield WE; Rao V
    J Thorac Cardiovasc Surg; 2016 Sep; 152(3):683-5. PubMed ID: 27210469
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HeartMate 3 Left Ventricular Assist Device Improves Long-Term Cerebral Hemodynamics.
    Favilla CG; Carter S; Atluri P; Reehal N; Genuardi MV
    Circ Heart Fail; 2023 Nov; 16(11):e010675. PubMed ID: 37929601
    [No Abstract]   [Full Text] [Related]  

  • 6. Anesthesia for the first successful HeartMate II left ventricular assist device implantation in Taiwan.
    Lin YS; Cheng HL; Chao A
    J Formos Med Assoc; 2014 Nov; 113(11):879-80. PubMed ID: 25443358
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device.
    Frazier OH; Gemmato C; Myers TJ; Gregoric ID; Radovancevic B; Loyalka P; Kar B
    Tex Heart Inst J; 2007; 34(3):275-81. PubMed ID: 17948075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Survival After HeartMate 3 Left Ventricular Assist Device Implantation-Progress Continues.
    Milam AJ; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2023 Aug; 37(8):1347-1348. PubMed ID: 37149472
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Invited commentary.
    Lodge AJ
    Ann Thorac Surg; 2008 May; 85(5):1650. PubMed ID: 18442557
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering a Brighter Future: The Evolving Role of the Pharmacist in the Era of the HeartMate 3.
    Ciolek AM; Littlefield AJ; Jennings DL
    Ann Pharmacother; 2019 Apr; 53(4):430-433. PubMed ID: 30404537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3.
    Wert L; Hanke JS; Rojas SV; Dogan G; Feldmann C; Rodt T; Haverich A; Schmitto JD
    Artif Organs; 2018 Feb; 42(2):242-244. PubMed ID: 29436023
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological changes in porcine bioprosthetic valves of a HeartMate left ventricular assist device.
    Khan NA; Butany J; Zhou T; Leong S; Rao V; Ross H
    Can J Cardiol; 2010; 26(7):e270-2. PubMed ID: 20847975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Safety and Feasibility of Portable Low-Field Magnetic Resonance Imaging With HeartMate 3 Left Ventricular Assist Device.
    Khanduja S; Rando H; Chinedozi ID; Kang JK; Darby Z; Trusch K; Pitts J; Whitman G; Cho SM; Kim BS
    ASAIO J; 2024 Mar; 70(3):e46-e48. PubMed ID: 37816009
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral mini-thoracotomy approach for minimally invasive implantation of HeartMate 3.
    Carrozzini M; Bejko J; Gerosa G; Bottio T
    Artif Organs; 2019 Jun; 43(6):593-595. PubMed ID: 30412274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biventricular support using 2 HeartMate 3 pumps.
    Potapov EV; Kukucka M; Falk V; Krabatsch T
    J Heart Lung Transplant; 2016 Oct; 35(10):1268-1270. PubMed ID: 27569985
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients.
    Pinsino A; Gaudig A; Castagna F; Mondellini GM; McDonnell BJ; Stöhr EJ; Cockcroft J; Kormos RL; Sayer GT; Uriel N; Naka Y; Takeda K; Yuzefpolskaya M; Colombo PC
    ASAIO J; 2024 Feb; 70(2):e18-e20. PubMed ID: 37429021
    [No Abstract]   [Full Text] [Related]  

  • 18. State of the art: implantable ventricular assist devices.
    Lahpor JR
    Curr Opin Organ Transplant; 2009 Oct; 14(5):554-9. PubMed ID: 19667990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved mechanical reliability of the HeartMate XVE left ventricular assist system.
    Pagani FD; Long JW; Dembitsky WP; Joyce LD; Miller LW
    Ann Thorac Surg; 2006 Oct; 82(4):1413-8. PubMed ID: 16996944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-Cause and Cause-Specific 30-Day Readmissions After Left Ventricular Assist Device Implantation: Comparing the HeartMate 3 Versus Pre-HeartMate 3 Eras.
    Almani MU; Aliyev N; Qudrat-Ullah M; Khan MS; Greene SJ
    Am J Cardiol; 2023 Nov; 207():82-83. PubMed ID: 37734304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.